Target intelligence / Profile preview

CTDNEP1 pseudogene 2 (CTDNEP1P2)

Target: CTDNEP1P2
Molecular classification: Other (Pseudogene)

Overview

CTDNEP1 pseudogene 2 (CTDNEP1P2) is a processed pseudogene corresponding to the CTD nuclear envelope phosphatase 1 gene. Unlike its parent gene CTDNEP1, which does encode a membrane-associated serine/threonine phosphatase involved in nuclear envelope and endoplasmic reticulum membrane regulation, CTDNEP1P2 is not protein encoding. There is no evidence for this pseudogene functioning as a molecular target, biological effector, or clinical biomarker[3].

Other names: CTDNEP1P2

Beyond the preview

Go deeper on CTDNEP1 pseudogene 2 (CTDNEP1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTDNEP1 pseudogene 2 (CTDNEP1P2).

Explore the full profile